C4 Therapeutics Inc (CCCC)

C4 Therapeutics Inc (CCCC) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $325M; returns 1 day -3.8%, 1 week +10.7%, 1 year +28.6%.

C4 Therapeutics (C4T) is a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation (TPD) science to create a new generation of medicines. Their revenue model hinges on their proprietary Targeted Protein Degradation (TPD) science, the TORPEDO® platform, which they are monetizing through big pharma deals like those with Roche and Biogen.

Groups CCCC belongs to

• Healthcare
• Biotechnology
• Clinical Stage Biotech
• Life Sciences
• Drug Discovery
• Oncology
• Cancer Therapeutics
• Biopharmaceutical
• Clinical Stage Biopharma
• R&D
• Strategic Partnerships

CCCC financial model: income statement, cash flow and balance sheet